Trial intelligence / Profile preview

Super-oxidised solution for perforated appendicitis

NCT04512196Completed

Sponsor
Queen Elizabeth Hospital
Start
Sep 2020
Primary completion
Mar 2022
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

Randomised, double-blind trial of hypochlorous acid in perforated appendicitis (2 arms), sponsored by Queen Elizabeth Hospital. Primary endpoint: Surgical site infection at 30 days. Started Sep 2020; status: completed.

02

Drugs

hypochlorous acid
03

Conditions

perforated appendicitis

Beyond the preview

Go deeper on NCT04512196.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04512196.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call